Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
Clinical trial NCT03912974 · COMPLETED
Trial details
- NCT number
- NCT03912974
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2020-11-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.